Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TaoWeave (TWAV) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for TaoWeave (TWAV) over the last 16 years, with Q3 2025 value amounting to $3.1 million.

  • TaoWeave's Shares Outstanding (Weighted Average) rose 24808.41% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 24808.41%. This contributed to the annual value of $834000.0 for FY2024, which is 18464.16% up from last year.
  • TaoWeave's Shares Outstanding (Weighted Average) amounted to $3.1 million in Q3 2025, which was up 24808.41% from $1.6 million recorded in Q2 2025.
  • TaoWeave's 5-year Shares Outstanding (Weighted Average) high stood at $30.7 million for Q3 2021, and its period low was $243378.0 during Q3 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $2.1 million (2022), whereas its average is $5.2 million.
  • In the last 5 years, TaoWeave's Shares Outstanding (Weighted Average) surged by 48472.51% in 2021 and then crashed by 9328.21% in 2022.
  • Quarter analysis of 5 years shows TaoWeave's Shares Outstanding (Weighted Average) stood at $1.8 million in 2021, then grew by 16.08% to $2.1 million in 2022, then tumbled by 85.81% to $293000.0 in 2023, then soared by 184.64% to $834000.0 in 2024, then skyrocketed by 271.85% to $3.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $3.1 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.2 million for Q1 2025.